Massive Bio's multidisciplinary team has in-depth business and healthcare experience consisting of oncologists, molecular diagnostic scientists, reimbursement experts, and data scientists.
Dr. Selin Kurnaz, CEO and cofounder of Massive Bio. After emigrating from Turkey and completing a PhD at the University of Michigan, receiving multiple engineering degrees, Selin spent more than a decade specializing in delivering revenue enhancement, margin optimization and capital efficiency improvements for Healthcare and Life Science companies. Her startup, Massive Bio, brings the latest knowledge in cancer care to patients treated at community practices in the US and worldwide. Selin has written and spoke extensively about life sciences in tech and how to deliver information in creative ways. Massive Bio is an alumni of eLab and PhilipsHealthworks Precision Cancer Care start-up acceleration programs.
Dr. Arturo Loaiza-Bonilla is the current Vice Chairman of the Department of Medical Oncology at Cancer Treatment Centers of America (CTCA), Chief of Medical Oncology and Medical Director of Research at CTCA - Philadelphia. A dedicated practicing clinician, international speaker, and precision oncology expert with experience at the Abramson Cancer Center of the University of Pennsylvania, University of Miami, Johns Hopkins and the National Institutes of Health, his major interest focuses in the field of innovative approaches to optimize clinical workflows and trial design (adaptive trials, synthetic control arms, basket trials), and matching for oncology patients to phase 1-3 clinical and translational research cancer trials, integrating next-generation personalized molecular diagnostics, immunotherapy, biomarkers, previous therapies, and the patient's overall status in treatment decision making, with special interest in Artificial Intelligence-based / machine and deep learning platforms.
Mr. Culcuoglu leads operational strategy, global business initiatives, product and technology development at Massive Bio. Mr. Culcuoglu has developed several products over the past 20 years, primarily for the financial, media and health industry. A serial entrepreneur, Mr. Culcuoglu co-founded startups, where he also led business and sales operations as well technology and product development. Mr. Culcuoglu took senior roles at Thomson Reuters, Mubasher, KPMG, Sabrient Systems, Anadolu Agency, Merrill Lynch and Smeal College. Mr. Culcuoglu is an active board member in multiple start-ups and an owner of a media company. In addition, Mr. Culcuoglu holds an MBA degree from Pennsylvania State University and MA degree from University of Maastricht.
Kristin Johnston is an Oncology Certified Registered Nurse, and is Massive Bio's Chief Nursing Officer. She has more than a decade of experience in helping cancer patients explore options and has personally guided thousands of patients through the clinical trial decision and enrollment process. Her role is to answer clinical questions and ensure patients have the support they need throughout their partnership with Massive Bio.
Jo Marie Victor, as VP of Operations at Massive Bio, supports the mission, growth, profitability, compliance, business development strategy, enterprise customer relationship management, and overall operations of Massive Bio. Jo Marie has extensive experience in the healthcare industry specifically in customer service management, call center leadership, Human Resources, and overall operations metrics, process and workflows.
In her role as Lead Patient Advocate, Fiona works directly with our patients and families, guiding them through Massive Bio's innovative cancer care. Fiona is focused on providing patient and family teaching regarding the specific treatment options offered by Massive Bio. She will assist in identifying individual care needs and guide them through the process of finding the right treatment options for their specific case. Born and raised in the United Kingdom, Fiona came to the United States with her family. She has spent the past 14 years working in various positions within the healthcare field, including cardiology, colon and rectal, surgery, and general medicine. Caring for patients with acute needs in inpatient settings and subacute needs in outpatient settings, has enabled Fiona to evaluate medical concerns from a variety of perspectives.
Jason Freedman, MD, MSCE is a Board Certified Pediatric Oncologist who graduated with honors from Cornell University and received his medical degree Magna Cum Laude from Upstate Medical University in Syracuse, NY. Dr. Freedman completed his residency in Pediatrics at the Children’s Hospital of NY-Presbyterian (Columbia University) and served as Pediatric Chief Resident, thereafter. He completed fellowship training in Pediatric Hematology/Oncology at Children’s Hospital of Philadelphia (CHOP), during which time he earned a Master’s of Science in Clinical Epidemiology (MSCE) from the University of Pennsylvania.
Dr. Freedman is an attending physician in Oncology at CHOP, where he also has administrative and teaching responsibilities. Dr. Freedman’s clinical focus is blood and marrow transplantation and hematologic malignancies. He has a particular interest in quality improvement and supportive care, and serves on several national committees. Dr. Freedman has authored several textbook chapters and peer-reviewed articles on the care of children with cancer and has contributed to the development of clinical guidelines to standardize management of symptoms associated with cancer therapy.
As the Associate Marketing Specialist, Josh delivers marketing materials to patients directly, and through Massive Bio’s social media pages. Josh also focuses on creating informative and resourceful materials for cancer patients throughout the Massive Bio website. The Customer Relationship Management Software (CRM) is also managed by Josh, by supporting the patient advocates and their ability to provide resources to our cancer patients. Since graduating from West Virginia University last year with a degree in Marketing, Josh has learned about the cancer industry and what it means to help cancer patients through working with Massive Bio. Josh has utilized and adapted what he has learned to improve Massive Bio’s ability to help cancer patients.